Intratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008

Eigentler T, Heinzerling L, Krauss J, Weishaupt C, Ochsenreither S, Lebbe C, Mohr P, Oliva M, Oberoi HK, Terheyden P, Perez JMT, Robert C, Bauernfeind FG, Fluck M, Richtig E, Soria A, Kays SK, Schmitt-Bormann B, Falk M, Gnad-Vogt US (2021)


Publication Type: Conference contribution

Publication year: 2021

Journal

Publisher: ELSEVIER

City/Town: AMSTERDAM

Pages Range: S853-S853

Conference Proceedings Title: ANNALS OF ONCOLOGY

DOI: 10.1016/j.annonc.2021.08.1394

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Eigentler, T., Heinzerling, L., Krauss, J., Weishaupt, C., Ochsenreither, S., Lebbe, C.,... Gnad-Vogt, U.S. (2021). Intratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008. In ANNALS OF ONCOLOGY (pp. S853-S853). AMSTERDAM: ELSEVIER.

MLA:

Eigentler, T., et al. "Intratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008." Proceedings of the ANNALS OF ONCOLOGY AMSTERDAM: ELSEVIER, 2021. S853-S853.

BibTeX: Download